Boston Scientific (BSX) Valuation Reset After Watchman Growth Concerns And Intensifying Competition

Boston Scientific (BSX) stock has been under pressure after management flagged slowing growth in its Watchman heart implant business, a key contributor to earnings. The company reaffirmed full year ...

Boston Scientific shares fall 10% on Watchman weakness, competitive pressures

Boston Scientific Corp (NYSE:BSX) dropped 10% Wednesday after Chief Executive Mike Mahoney indicated that standalone Watchman heart implant procedures continue to decline and highlighted near-term ...

How Investors May Respond To Boston Scientific (BSX) Strong Q1 Beat But Cut Guidance On Watchman Growth

In late April 2026, Boston Scientific reported quarterly revenue of US$5.20 billion, up 11.6% year on year and ahead of ...

Boston Scientific hits two-year low after flagging weaker demand for heart device

By Kamal Choudhury May 27 (Reuters) - Boston Scientific shares sank to their lowest in over two years on Wednesday, after the medical device maker warned it was facing pressure due to softer uptake of ...
Gizmodo

I Miss the Sony Watchman

A lifelong obsession with technology has left me with drawers full of gadgets, many of which I don’t even remember buying. But the very first? That memory remains crystal clear. It was a Sony, one of ...